A patient has become the first in Wales to start on a revolutionary new genetic treatment for blood cancer.
CAR-T therapy involves genetically modifying a type of the body’s immune cells in the hope they will then recognise and destroy cancer cells.
John Davies, 71, from Blackwood, will have his blood frozen in Amsterdam, then modified in the United States before being transfused next month.
Despite chemotherapy for several years, John’s lymphoma has not been cured.
This is the first time in Wales the treatment has been offered after the go-ahead for NHS use last year.
The exact cost of the treatment is commercially sensitive but it is believed to be around a third of a million pounds.
In Wales, it is being funded by the Welsh Health Specialised Services Committee